These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26299867)

  • 41. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix.
    Christensen L
    APMIS Suppl; 1992; 26():1-39. PubMed ID: 1576006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
    Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
    Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation biomarkers for pleomorphic lobular breast cancer - a short report.
    Moelans CB; Vlug EJ; Ercan C; Bult P; Buerger H; Cserni G; van Diest PJ; Derksen PW
    Cell Oncol (Dordr); 2015 Oct; 38(5):397-405. PubMed ID: 26392358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer risk and imprinting methylation in blood.
    Harrison K; Hoad G; Scott P; Simpson L; Horgan GW; Smyth E; Heys SD; Haggarty P
    Clin Epigenetics; 2015; 7(1):92. PubMed ID: 26347357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer.
    Yan J; Yu X; Li Q; Miao M; Shao Y
    BMC Genomics; 2024 Mar; 25(1):319. PubMed ID: 38549047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
    Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
    Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Extracellular Matrix Proteins in Breast Cancer.
    Lepucki A; Orlińska K; Mielczarek-Palacz A; Kabut J; Olczyk P; Komosińska-Vassev K
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.
    Chou CW; Huang YM; Chang YJ; Huang CY; Hung CS
    Int J Med Sci; 2021; 18(12):2521-2531. PubMed ID: 34104083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.
    Zhao Y; Zheng X; Zheng Y; Chen Y; Fei W; Wang F; Zheng C
    Front Oncol; 2021; 11():650453. PubMed ID: 33968752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.
    Strelnikov VV; Kuznetsova EB; Tanas AS; Rudenko VV; Kalinkin AI; Poddubskaya EV; Kekeeva TV; Chesnokova GG; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Simonova OA
    Sci Rep; 2021 Jan; 11(1):2264. PubMed ID: 33500458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and Its Relation to Epigenomic Subtypes and HER2 Overexpression.
    Simonova OA; Kuznetsova EB; Tanas AS; Rudenko VV; Poddubskaya EV; Kekeeva TV; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Strelnikov VV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32397602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers.
    Fan S; Tang J; Li N; Zhao Y; Ai R; Zhang K; Wang M; Du W; Wang W
    NPJ Genom Med; 2019; 4():2. PubMed ID: 30729033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
    Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
    Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
    Sathyanarayana UG; Padar A; Suzuki M; Maruyama R; Shigematsu H; Hsieh JT; Frenkel EP; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6395-400. PubMed ID: 14695140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [DNA methylation in the promoter regions of the laminin family genes in normal and breast carcinoma tissues].
    Simonova OA; Kuznetsova EB; Poddubskaya EV; Kekeeva TV; Kerimov RA; Trotsenko ID; Tanas AS; Rudenko VV; Alekseeva EA; Zaletayev DV; Strelnikov VV
    Mol Biol (Mosk); 2015; 49(4):667-77. PubMed ID: 26299867
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.